Navigation Links
PDI Reports 2009 Second Quarter Financial Results
Date:8/5/2009

--------- -------- --------- -------- Operating loss (4,682) (7,900) (10,262) (9,608) Other income, net 60 800 163 1,950 --------- -------- --------- -------- Loss before income tax (4,622) (7,100) (10,099) (7,658) Provision for income tax 213 377 451 879 --------- -------- --------- -------- Net loss $(4,835) $(7,477) $(10,550) $(8,537) --------- -------- --------- -------- Loss per share of common stock: Basic $(0.34) $(0.52) $(0.74) $(0.60) Diluted $(0.34) $(0.52) $(0.74) $(0.60) Weighted average number of common shares and common share equivalents outstanding: Basic 14,210 14,292 14,216 14,257 Diluted 14,210 14,292 14,216 14,257 Segment Data (Unaudited) (in thousands) Product Elimin- Sales Marketing Commercial- ation Services Services ization Company Consolidated -------- -------- -------- -------- ------------ Three months ended June 30, 2009: Revenue $13,936 $3,918 $ - $(1,563) $16,291 Gross profit 2,323 1,837 2,486 236 6,882 Gross profit % 16.7% 46.9% 0.0% NM 42.2% Three months ended June 30, 2008: Revenue $23,401 $7,998 $(1,000) $ - $30,399 Gross profit 5,166 3,380 (4,956) - 3,590 Gross profit % 22.1% 42.3%
'/>"/>
SOURCE PDI, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
2. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
3. NxStage Reports Second Quarter 2009 Financial Results
4. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
5. Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
6. CuraGen Reports Second Quarter 2009 Financial Results
7. ERT Reports Second Quarter 2009 Results
8. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
9. Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
10. Caliper Life Sciences Reports Second Quarter 2009 Results
11. Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... N.J. , Feb. 26, 2015 On ... and its affiliated companies, Wilentz, Goldman & Spitzer, ... trade secrets lawsuit against Genewiz Inc. in excess of ... and utilized GenScript,s trade secrets, and that it improperly ... entered an order denying motions for judgment notwithstanding the ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
(Date:2/26/2015)... DuPont Executive Vice President James C. ... advancements and product launches across the Agriculture and Nutrition ... Lynch 2015 Global Agriculture Conference. "While ... the last two years, long-term demand for agricultural production ... last decade, when demand for corn and soybeans increased ...
(Date:2/26/2015)... 2015  NuGene International, Inc. ("NuGene") (OTCQB: NUGN), ... and hair rejuvenation, has announced that it has ... for investor relations and strategic communications. ... and diversification strategies – and we need to ... stated Ali Kharazmi CEO of NuGene when announcing ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3
... BMY ) will announce results for the fourth ... During a 10 a.m. (ET) conference call,on Jan. 31, ... from investors and analysts., Investors and the general ... the call at http://www.bms.com/ir or by dialing ...
... Product Progresses in Phase 2 ... ... ), a biotechnology company focused on the development of,compounds for the treatment ... as senior vice president of research,and development. Dr. Taub brings extensive experience ...
... Preparing for the NFL, Combine Use SURGEX(TM) as part of ... ... Clubs(TM), BASKING RIDGE, N.J., Jan. 15 ... MBTG), announced today that SURGEX(TM) is,currently being administered as part of ...
Cached Biology Technology:VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 2VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 3VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development 4Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as Part of Their Pre-Combine Training Regime 2Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as Part of Their Pre-Combine Training Regime 3Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as Part of Their Pre-Combine Training Regime 4
(Date:2/25/2015)... , Feb. 25, 2015  ABC Financial Services ... in the Health and Fitness Industry, today announced ... to MYiCLUBonline.  The latest upgrade includes advances to ... of cardless check-in via Identity One fingerprint biometrics. ... time through interactive displays at the International Health, ...
(Date:2/19/2015)... Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ... "Military Electro-Optical / Infrared Systems Market by Type, ... Forecast to 2020" report to their offering. ... is expected to reach $16.35 billion by 2020, ... This report segments the military electro-optical/infrared systems market ...
(Date:2/11/2015)... 11, 2015 According ... Control Market by Product (Cards and Readers, Biometrics, Controllers, ... Government, Industrial, Healthcare, Education) and By Geography - Global Forecast and ... the Access Control Market is expected to ... a CAGR of 10.6% between 2014 and ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... movementfrom the blink of an eye to running a marathonnerve ... cells rely on tiny molecular motors to transport chemical messengers ... process, which scientists are still trying to understand. A new ... of the puzzle. The study, published in the April ...
... in French . Montreal, May 25, 2011 ... do it, too. But when it comes to securing a mate ... A group of scientists from Simon Fraser University, Concordia ... the key to reproductive success when males outnumber females. The ...
... been tracked inside a living human cell and may lead ... Professor Lloyd Hollenberg from the University of Melbourne,s School ... first time a single atom encased in nanodiamond has been ... a living human cell. "It is exciting to see ...
Cached Biology News:Syracuse University scientists discover new hitch to link nerve cell motors to their cargo 2Mating rivalry among furred and feathered: Variety is spice of life 2Quantum sensor tracked in human cells could aid drug discovery 2
Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
Mouse monoclonal antibody to RNase L...
Anti (porcine) Vitronectin...
... Rabbit polyclonal to BMP2 BMP2 ... beta (TGFB) superfamily. Bone morphogenic protein ... candidate gene for the autosomal dominant ... Immunogen: Synthetic peptide: ...
Biology Products: